Lion Point Capital, LP

Holdings History for LUMOS PHARMA INC - Common Stock (LUMO)

Symbol: LUMO on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2024		-0.61%	$0	0	-39,589	-100%		Q4 2024
30 Sep 2024	0.61%	-0.79%	$153,209	39,589	-51,205	-56%	$3.87	Q3 2024
30 Jun 2024	0.66%	0%	$210,642	90,794	0		$2.32	Q2 2024
31 Mar 2024	0.49%	0%	$256,039	90,794	0		$2.82	Q1 2024
31 Dec 2023	0.26%	0%	$288,725	90,794	0		$3.18	Q4 2023
30 Sep 2023	0.27%	+0.04%	$299,620	90,794	+12,443	+16%	$3.30	Q3 2023
30 Jun 2023	0.19%	+0.07%	$258,558	78,351	+27,146	+53%	$3.30	Q2 2023
31 Mar 2023	0.09%	0%	$169,489	51,205	0		$3.31	Q1 2023
31 Dec 2022		0%	$732,000	51,205	0		$14.30 ^*	Q4 2022
30 Sep 2022		0%	$732,000	51,205	0		$14.30 ^*	Q3 2022
30 Jun 2022		0%	$732,000	51,205	0		$14.30 ^*	Q2 2022
31 Mar 2022	0.16%	0%	$481,000	51,205	0		$9.39	Q1 2022
31 Dec 2021	0.12%	-0.81%	$354,000	51,205	-355,987	-87%	$6.91	Q4 2021
30 Sep 2021	1%	0%	$3,872,000	407,192	0		$9.51	Q3 2021
30 Jun 2021	0.96%	0%	$4,071,000	407,192	0		$10.00	Q2 2021
31 Mar 2021	1.2%	0%	$4,764,000	407,192	0		$11.70	Q1 2021
31 Dec 2020	3%	0%	$14,540,000	407,192	0		$35.71	Q4 2020
30 Sep 2020	1.3%	0%	$5,627,000	407,192	0		$13.82	Q3 2020
30 Jun 2020	1.7%	0%	$6,714,000	407,192	0		$16.49	Q2 2020
31 Mar 2020	1.2%	+1.2%	$3,461,000	407,192	+407,192	NEW	$8.50	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.